World's Best Scientists 2026 revealed!
Stephen J. Nicholls

Stephen J. Nicholls

D-Index & Metrics

Medicine

D-Index
108
Citations
66641
World Ranking
5879
National Ranking
164

Overview

Stephen J. Nicholls is affiliated with Monash University in Australia and specializes in medicine with a primary focus on cardiology and cardiovascular medicine. Their extensive body of work includes significant contributions across several subfields such as surgery, radiology, nuclear medicine and imaging, endocrinology, diabetes and metabolism, as well as economics and econometrics.

The main topics of their research encompass lipoproteins and cardiovascular health, cardiac imaging and diagnostics, coronary interventions and diagnostics, diabetes, cardiovascular risks and lipoproteins, cancer, lipids and metabolism, health systems including economic evaluations and quality of life, and cardiovascular disease and adiposity.

Stephen J. Nicholls has published frequently in prominent venues, notably:

  • Heart Lung and Circulation (92 publications)
  • Journal of the American College of Cardiology (47 publications)
  • European Heart Journal (38 publications)
  • Atherosclerosis (21 publications)
  • Circulation (19 publications)

They have collaborated recurrently with several researchers, including:

  • Adam J. Nelson
  • Steven E. Nissen
  • Nitesh Nerlekar
  • Peter J. Psaltis
  • A. Michael Lincoff

Among their recent scholarly articles are:

  • "Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk," 2020, published in JAMA
  • "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure," 2020, published in New England Journal of Medicine
  • "Empagliflozin in Heart Failure with a Preserved Ejection Fraction," 2021, published in New England Journal of Medicine
  • "Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel," 2020, published in European Heart Journal
  • "Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients," 2023, published in New England Journal of Medicine

Best Publications

  • Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

    M. Packer;S. D. Anker;J. Butler;G. Filippatos

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray

  • Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

    Steven E. Nissen;Stephen J. Nicholls;Ilke Sipahi;Peter Libby

  • Empagliflozin in heart failure with a preserved ejection fraction

    Stefan D Anker;Javed Butler;Gerasimos Filippatos;João P Ferreira

  • Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

    Gregory G. Schwartz;Anders G. Olsson;Markus Abt;Christie M. Ballantyne

  • Antiinflammatory Properties of HDL

    Philip J. Barter;Stephen Nicholls;Kerry Anne Rye;G. M. Anantharamaiah

  • Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

    A. Michael Lincoff;Kathy Wolski;Stephen J. Nicholls;Steven E. Nissen

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard

  • Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

    Stephen J. Nicholls;Christie M. Ballantyne;Philip J. Barter;M. John Chapman

  • Effect of Torcetrapib on the Progression of Coronary Atherosclerosis

    Steven E. Nissen;Jean Claude Tardif;Stephen J. Nicholls;James H. Revkin

  • Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

    Min Jun;Celine Foote;Jicheng Lv;Jicheng Lv;Bruce Neal

  • Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

    Stephen J. Nicholls;Stephen J. Nicholls;Rishi Puri;Todd Anderson;Christie M. Ballantyne

  • Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: The PERISCOPE Randomized Controlled Trial

    Steven E. Nissen;Stephen J. Nicholls;Kathy Wolski;Richard Nesto

  • Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis

    Stephen J. Nicholls;E. Murat Tuzcu;Ilke Sipahi;Adam W. Grasso

  • Myeloperoxidase and Cardiovascular Disease

    Stephen J. Nicholls;Stanley L. Hazen

  • Protein carbamylation links inflammation, smoking, uremia and atherogenesis

    Zeneng Wang;Stephen J Nicholls;E Rene Rodriguez;Outi Kummu

  • Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

    A. Michael Lincoff;Stephen J. Nicholls;Jeffrey S. Riesmeyer;Philip J. Barter

  • Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis

    Steven E. Nissen;Stephen J. Nicholls;Ilke Sipahi;Peter Libby

  • Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus

    A. Michael Lincoff;Kathy Wolski;Stephen J. Nicholls;Steven E. Nissen

  • Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

    Nicholls Sj;Ballantyne Cm;Barter Pj;Chapman Mj

Frequent Co-Authors

Steven E. Nissen
Steven E. Nissen Cleveland Clinic
E. Murat Tuzcu
E. Murat Tuzcu Cleveland Clinic
Samir R. Kapadia
Samir R. Kapadia Cleveland Clinic
Philip J. Barter
Philip J. Barter University of New South Wales
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Kausik K. Ray
Kausik K. Ray Imperial College London
Stanley L. Hazen
Stanley L. Hazen Cleveland Clinic Lerner College of Medicine
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
A. Michael Lincoff
A. Michael Lincoff Cleveland Clinic
Peter Libby
Peter Libby Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean attending traditional, on-campus programs. Today, many students begin or advance their healthcare careers through online nursing programs. These flexible options make it easier for working professionals and those with busy schedules to achieve their goals.

For registered nurses looking to deepen their expertise and leadership skills, a Doctor of Nursing Practice (DNP) is a valuable step—especially with the availability of cheapest dnp programs online. Likewise, RNs hoping to complete their bachelor’s degree in nursing can find affordable opportunities among the cheapest rn to bsn online programs, opening doors to advanced roles and higher salaries.

If you hold a non-nursing bachelor’s degree and want to switch to nursing, online direct entry msn programs for non-nursing majors enable a fast transition into the field. Choosing the right online degree can pave the way to a fulfilling healthcare career, whether in clinical practice, research, or administration.

Best Scientists Citing Stephen J. Nicholls

Trending Scientists